Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib

Published:2008-11-07 Issue:2 Volume:24 Page:682-685
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Bollee G.,Patey N.,Cazajous G.,Robert C.,Goujon J.-M.,Fakhouri F.,Bruneval P.,Noel L.-H.,Knebelmann B.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/24/2/682/7635783/gfn657.pdf

Reference15 articles.

1. Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis

2. VEGF Inhibition and Renal Thrombotic Microangiopathy

3. Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma

4. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome

5. The Case ∣ Progressive hypertension and proteinuria on anti-angiogenic therapy

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent disease after pediatric renal transplantation;Pediatric Transplantation;2024-04-23

2. A Case of Acute Kidney Injury, Proteinuria, and Thrombotic Microangiopathy Associated With Sunitinib Therapy in Metastatic Pancreatic Neuroendocrine Tumor;Cureus;2024-03-21

3. Machine learning application identifies plasma markers for proteinuria in metastatic colorectal cancer patients treated with Bevacizumab;Cancer Chemotherapy and Pharmacology;2024-02-25

4. Chronic thrombotic microangiopathy presenting as acute nephrotic syndrome in a patient with renal cancer receiving tyrosine kinase inhibitor therapy;BMJ Case Reports;2024-01

5. Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney;The American Journal of the Medical Sciences;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3